COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
| Autor: | Askenase, Philip W.1 (AUTHOR) philip.askenase@yale.edu |
|---|---|
| Zdroj: | Journal of Extracellular Vesicles. Nov2020, Vol. 10, p1-19. 19p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|